Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-09 10:32 am Purchase | 13G | CELCUITY INC CELC | Soleus Capital Master Fund L.P. | 2,623,890 9.9% | 338,336 (+14.80%) | View |
| 2024-02-08 10:08 am Purchase | 13G | CALCIMEDICA INC CALC | Soleus Capital Master Fund L.P. | 1,105,016 9.99% | 321,112 (+40.96%) | View |
| 2024-02-05 10:24 am Purchase | 13G | C4 THERAPEUTICS INC CCCC | Soleus Capital Master Fund L.P. | 2,555,996 5.2% | 720,000 (+39.22%) | View |
| 2024-02-02 09:59 am Sale | 13G | PIERIS PHARMACEUTICALS INC PIRS | Soleus Capital Master Fund L.P. | 0 0% | -4,000,000 (Position Closed) | View |
| 2024-02-02 09:56 am Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | Soleus Capital Master Fund L.P. | 9,442,579 5.4% | 219,564 (+2.38%) | View |
| 2024-02-02 09:54 am Purchase | 13G | ORGANOGENESIS HLDGS INC CLASS ORGO | Soleus Capital Master Fund L.P. | 8,963,000 6.8% | 1,599,937 (+21.73%) | View |
| 2024-02-02 09:53 am Sale | 13G | SURMODICS INC SRDX | Soleus Capital Master Fund L.P. | 771,700 5.4% | -3,611 (-0.47%) | View |
| 2024-02-02 09:50 am Purchase | 13G | JASPER THERAPEUTICS INC NE JSPR | Soleus Capital Master Fund L.P. | 987,096 8.8% | 987,096 (New Position) | View |
| 2024-02-02 09:49 am Purchase | 13G | VERASTEM INC VSTM | Soleus Capital Master Fund L.P. | 1,425,634 6.8% | 128,265 (+9.89%) | View |
| 2024-02-02 09:44 am Sale | 13G | IRADIMED CORP COM IRMD | Soleus Capital Master Fund L.P. | 643,206 5.1% | -101,798 (-13.66%) | View |
| 2024-02-02 09:42 am Sale | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Soleus Capital Master Fund L.P. | 703,868 5% | -187,000 (-20.99%) | View |
| 2024-02-02 09:41 am Purchase | 13G | EDAP TMS S.A. SPONS ADR EDAP | Soleus Capital Master Fund L.P. | 7,226,341 19.6% | 2,091,911 (+40.74%) | View |
| 2024-02-02 09:37 am Sale | 13G | DELCATH SYS INC DCTH | Soleus Capital Master Fund L.P. | 0 0% | -806,420 (Position Closed) | View |
| 2024-02-02 09:34 am Sale | 13G | C4 THERAPEUTICS INC CCCC | Soleus Capital Master Fund L.P. | 1,835,996 3.7% | -626,024 (-25.43%) | View |
| 2024-02-02 09:29 am Sale | 13G | AXOGEN, INC. AXGN | Soleus Capital Master Fund L.P. | 2,595,815 6% | -945,483 (-26.70%) | View |
| 2024-01-26 4:15 pm Purchase | 13G | CALCIMEDICA INC CALC | Soleus Capital Master Fund L.P. | 783,904 7.4% | 783,904 (New Position) | View |
| 2023-11-28 4:52 pm Purchase | 13D | THERATECHNOLOGIES INC THTX | Soleus Capital Master Fund L.P. | 5,188,876 10.5% | 5,188,876 (New Position) | View |
| 2023-11-02 4:15 pm Purchase | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Soleus Capital Master Fund L.P. | 890,868 6.4% | 890,868 (New Position) | View |
| 2023-08-16 4:30 pm Purchase | 13G | DELCATH SYS INC DCTH | Soleus Capital Master Fund L.P. | 806,420 5.3% | 806,420 (New Position) | View |
| 2023-08-11 4:31 pm Purchase | 13G | AXOGEN, INC. AXGN | Soleus Capital Master Fund L.P. | 3,541,298 8.2% | 3,541,298 (New Position) | View |